Loading clinical trials...
Loading clinical trials...
The aim of this study is to establish FET-PET as an additional therapy assessment parameter in patients diagnosed with a glioblastoma multiforme receiving radiochemotherapy and adjuvant chemotherapy a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ludwig-Maximilians - University of Munich
Collaborators
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT01269853 · Glioblastoma Multiforme, Anaplastic Astrocytoma
NCT05954858 · Glioma, Malignant, Glioblastoma, and more
NCT05271240 · Glioblastoma, Glioblastoma Multiforme, and more
Department of Stereotactic Neurosurgery
Freiburg im Breisgau, Baden-Wurttemberg
University Hospital Munich, Department of Neurosurgery
Munich, Bavaria
University Hospital Bonn, Department of Neurosurgery
Bonn, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions